{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:51:55Z","timestamp":1794084715517,"version":"4.8.0"},"reference-count":132,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Opportunistic fungal infections have high mortality in patients with severe immune dysfunction. Growing evidence suggests that the immune environment of invasive fungal infections and cancers share common features of immune cell exhaustion through activation of immune checkpoint pathways. This observation gave rise to several preclinical studies and clinical case reports describing blockade of the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte Antigen 4 immune checkpoint pathways as an adjunct immune enhancement strategy to treat opportunistic fungal infections. The first part of this review summarizes the emerging evidence for contributions of checkpoint pathways to the immunopathology of fungal sepsis, opportunistic mold infections, and dimorphic fungal infections. We then review the potential merits of immune checkpoint inhibitors (ICIs) as an antifungal immunotherapy, including the incomplete knowledge of the mechanisms involved in both immuno-protective effects and toxicities. In the second part of this review, we discuss the limitations of the current evidence and the many unknowns about ICIs as an antifungal immune enhancement strategy. Based on these gaps of knowledge and lessons learned from cancer immunology studies, we outline a research agenda to determine a \u201csweet spot\u201d for ICIs in medical mycology. We specifically discuss the importance of more nuanced animal models, the need to study ICI-based combination therapy, potential ICI resistance, the role of the immune microenvironment, and the impact of ICIs given as part of oncological therapies on the natural immunity to various pathogenic fungi.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1018202","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T02:21:28Z","timestamp":1666664488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions"],"prefix":"10.3389","volume":"13","author":[{"given":"Sebastian","family":"Wurster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie S.","family":"Watowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-020-00379-2","article-title":"Azole-resistant aspergillus and echinocandin-resistant candida - what are the treatment options","volume":"14","author":"Novak","year":"2020","journal-title":"Curr Fungal Infect Rep"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1070","article-title":"Investigational antifungal agents for invasive mycoses: a clinical perspective","volume":"75","author":"Lamoth","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/jof7030217","article-title":"Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer","volume":"7","author":"Axell-House","year":"2021","journal-title":"J Fungi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/mmy\/myu036","article-title":"Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"52","author":"van de Peppel","year":"2014","journal-title":"Med Mycol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01612","article-title":"Immunomodulation as therapy for fungal infection: Are we closer","volume":"9","author":"Sam","year":"2018","journal-title":"Front Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcyt.2015.09.013","article-title":"Stimulation with lysates of aspergillus terreus, candida krusei and rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells","volume":"18","author":"Deo","year":"2016","journal-title":"Cytotherapy;"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2015.05.011","article-title":"Clinical-scale isolation of the total aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer","volume":"17","author":"Bacher","year":"2015","journal-title":"Cytotherapy;"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw513","article-title":"Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis","volume":"215","author":"Baistrocchi","year":"2017","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/jof4040137","article-title":"Immunomodulation as a therapy for aspergillus infection: Current status and future perspectives","volume":"4","author":"Lauruschkat","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/jof7060451","article-title":"Reinforcing the immunocompromised host defense against fungi: Progress beyond the current state of the art","volume":"7","author":"Karavalakis","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/02681219680000101","article-title":"Granulocyte-macrophage colony-stimulating factor and inter-feron-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against aspergillus fumigatus hyphae","volume":"34","author":"Roilides","year":"1996","journal-title":"J Med Vet Mycol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki252","article-title":"Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF","volume":"56","author":"Sionov","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"B16","article-title":"G-CSF and GM-CSF in neutropenia","volume":"195","author":"Mehta","year":"1995","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of granulocyte-macrophage colony-stimulating fac-tor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: a prospective multicenter randomized phase IV trial","volume":"33","author":"Wan","year":"2015","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000342121","article-title":"Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease","volume":"129","author":"Safdar","year":"2013","journal-title":"Acta Haematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.08.004","article-title":"Checkpoint inhibition and infectious diseases: A good thing","volume":"25","author":"Abers","year":"2019","journal-title":"Trends Mol Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: Similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12834","article-title":"Understanding the CD28\/CTLA-4 (CD152) pathway and its implications for costimulatory blockade","volume":"14","author":"Gardner","year":"2014","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1556\/1886.2019.00011","article-title":"Immune response in bacterial and candida sepsis","volume":"9","author":"Patricio","year":"2019","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T Cells from patients with candida sepsis display a suppressive immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.12.009","article-title":"T-Cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option","volume":"84","author":"Mellinghoff","year":"2022","journal-title":"J Infect"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181d8cc1d","article-title":"Long-term mortality and quality of life in sepsis: a systematic review","volume":"38","author":"Winters","year":"2010","journal-title":"Crit Care Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2016.08.099","article-title":"Anti-PD-L1 peptide improves survival in sepsis","volume":"208","author":"Shindo","year":"2017","journal-title":"J Surg Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1942228","article-title":"Single-cell immune checkpoint landscape of PBMCs stimulated with candida albicans","volume":"10","author":"Deng","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00817-21","article-title":"Candida auris bloodstream infection induces upregulation of the PD-1\/PD-L1 immune checkpoint pathway in an immunocompetent mouse model","volume":"7","author":"Wurster","year":"2022","journal-title":"mSphere;"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700840","article-title":"Anti-PD-1 antibody treatment promotes clearance of persistent cryptococcal lung infection in mice","volume":"199","author":"Roussey","year":"2017","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0234OC","article-title":"PD-1 deficiency promotes macrophage activation and T-helper cell type 1\/T-helper cell type 17 response in pneumocystis pneumonia","volume":"62","author":"Zhang","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02686-14","article-title":"Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during pneumocystis pneumonia","volume":"83","author":"Lei","year":"2015","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1016\/j.jaci.2004.12.1042","article-title":"Enhanced expression of CTLA-4 and concurrent downregulation of CD28 on lung cells of mice exposed to aspergillus antigen","volume":"15","author":"Barrios","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jof3040055","article-title":"The multifaceted role of T-helper responses in host defense against aspergillus fumigatus","volume":"3","author":"Dewi","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1038\/s41598-017-11738-4","article-title":"Toll-like receptor 2 induced cytotoxic T-lymphocyte-associated protein 4 regulates aspergillus-induced regulatory T-cells with pro-inflammatory characteristics","volume":"7","author":"Raijmakers","year":"2017","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix469","article-title":"Aspergillus fumigatus cell wall \u03b1-(1,3)-Glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells","volume":"216","author":"Stephen-Victor","year":"2017","journal-title":"J Infect Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1086\/374646","article-title":"Fas-fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis","volume":"187","author":"Campanelli","year":"2003","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711918105","article-title":"The PD-1\/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus histoplasma capsulatum","volume":"105","author":"L\u00e1z\u00e1r-Moln\u00e1r","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.8.4624-4630.2000","article-title":"CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response","volume":"68","author":"McGaha","year":"2000","journal-title":"Infect Immun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/SHK.0b013e3182168cce","article-title":"Dose-dependent effect of anti-CTLA-4 on survival in sepsis","volume":"36","author":"Inoue","year":"2011","journal-title":"Shock;"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001392","article-title":"Blockade of PD-1 attenuated postsepsis aspergillosis Via the activation of IFN-\u03b3 and the dampening of IL-10","volume":"53","author":"Vu","year":"2020","journal-title":"Shock;"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa264","article-title":"Protective activity of programmed cell death protein 1 blockade and synergy with caspofungin in a murine invasive pulmonary aspergillosis model","volume":"222","author":"Wurster","year":"2020","journal-title":"J Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2011.615877","article-title":"Immunomodulatory properties of antifungal agents on phagocytic cells","volume":"40","author":"Simitsopoulou","year":"2011","journal-title":"Immunol Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1086\/589290","article-title":"Immunocompromised hosts: immunopharmacology of modern antifungals","volume":"47","author":"Ben-Ami","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1086\/589305","article-title":"Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against aspergillus and non-aspergillus hyphae","volume":"198","author":"Lamaris","year":"2008","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838344","article-title":"Blockade of the PD-1\/PD-L1 immune checkpoint pathway improves infection outcomes and enhances fungicidal host defense in a murine model of invasive pulmonary mucormycosis","volume":"13","author":"Wurster","year":"2022","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000530","article-title":"Immune checkpoint blockade for aspergillosis and mucormycosis coinfection","volume":"5","author":"Banck","year":"2021","journal-title":"Hemasphere;"},{"key":"B54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mmcr.2022.06.003","article-title":"Nivolumab and interferon-\u03b3 rescue therapy to control mixed mould and bacterial superinfection after necrotizing fasciitis and septic shock","volume":"37","author":"Lukaszewicz","year":"2022","journal-title":"Med Mycol Case Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900522","article-title":"Case report: Immune checkpoint blockade plus interferon-\u0393 add-on antifungal therapy in the treatment of refractory covid-associated pulmonary aspergillosis and cerebral mucormycosis","volume":"13","author":"Serris","year":"2022","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.06.035","article-title":"Nivolumab induces long-term remission in a patient with fusariosis","volume":"173","author":"Khatamzas","year":"2022","journal-title":"Eur J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-280X.1999.00247.x","article-title":"Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice","volume":"37","author":"van Enckevort","year":"1999","journal-title":"Med Mycol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.585311","article-title":"Biomarkers of checkpoint inhibitor induced immune-related adverse events-a comprehensive review","volume":"10","author":"Hommes","year":"2021","journal-title":"Front Oncol."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0051ED","article-title":"Pneumocystis pneumonia: Checkpoint inhibition to the rescue","volume":"62","author":"Better","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.289","article-title":"Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab","volume":"6","author":"Uchida","year":"2017","journal-title":"Respirol Case Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2712","article-title":"Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none","volume":"10","author":"Barber","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0277","article-title":"Infectious complications and immunotherapy: old pitfalls and new horizons","volume":"18","author":"Lasagna","year":"2022","journal-title":"Future Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.03.022","article-title":"Overview of vertebrate animal models of fungal infection","volume":"410","author":"Hohl","year":"2014","journal-title":"J Immunol Methods"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00841","article-title":"Rodent models of invasive aspergillosis due to aspergillus fumigatus: Still a long path toward standardization","volume":"8","author":"Desoubeaux","year":"2017","journal-title":"Front Microbiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-708511","article-title":"Inducible epithelial resistance protects mice against leukemia-associated pneumonia","volume":"128","author":"Leiva-Ju\u00e1rez","year":"2016","journal-title":"Blood;"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00339-19","article-title":"Experimental mouse models of disseminated candida auris infection","volume":"4","author":"Xin","year":"2019","journal-title":"mSphere;"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1080\/13693780701644140","article-title":"Animal models: an important tool in mycology","volume":"45","author":"Capilla","year":"2007","journal-title":"Med Mycol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","article-title":"Epidemiology, clinical characteristics, resistance, and treatment of infections by candida auris","volume":"6","author":"Cortegiani","year":"2018","journal-title":"J Intensive Care"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive candida infection in critically ill patients: A systematic review and meta-analysis","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest;"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00538","article-title":"A framework for understanding the evasion of host immunity by candida biofilms","volume":"9","author":"Garcia-Perez","year":"2018","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.celrep.2019.07.028","article-title":"Microbial exposure enhances immunity to pathogens recognized by TLR2 but increases susceptibility to cytokine storm through TLR4 sensitization","volume":"28","author":"Huggins","year":"2019","journal-title":"Cell Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/microorganisms9051062","article-title":"Consideration of gut microbiome in murine models of diseases","volume":"9","author":"Zhang","year":"2021","journal-title":"Microorganisms;"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01695-5","article-title":"Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma","volume":"28","author":"Lee","year":"2022","journal-title":"Nat Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669150","article-title":"Modulation of gut microbiota to enhance effect of checkpoint inhibitor immunotherapy","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000067","article-title":"Influenza suppresses neutrophil recruitment to the lung and exacerbates secondary invasive pulmonary aspergillosis","volume":"205","author":"Tobin","year":"2020","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2017.136","article-title":"Hallmarks of response to immune checkpoint blockade","volume":"117","author":"Cogdill","year":"2017","journal-title":"Br J Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gendis.2019.12.004","article-title":"Immune checkpoint: The novel target for antitumor therapy","volume":"8","author":"Jiang","year":"2019","journal-title":"Genes Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11912-020-00983-y","article-title":"Alternative checkpoints as targets for immunotherapy","volume":"22","author":"Pant","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00175","article-title":"TIGIT blockade: A multipronged approach to target the HIV reservoir","volume":"10","author":"Holder","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0097","article-title":"Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors","volume":"3","author":"Thommen","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"100738","DOI":"10.1016\/j.tranon.2019.12.010","article-title":"Resistance to checkpoint inhibition in cancer immunotherapy","volume":"13","author":"Barrueto","year":"2020","journal-title":"Transl Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1653744","article-title":"Concepts for agonistic targeting of CD40 in immuno-oncology","volume":"16","author":"Richards","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00034","article-title":"OX40 agonists and combination immunotherapy: Putting the pedal to the metal","volume":"5","author":"Linch","year":"2015","journal-title":"Front Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01381","article-title":"Candida-reactive T cells for the diagnosis of invasive candida infection-a prospective pilot study","volume":"9","author":"Koehler","year":"2018","journal-title":"Front Microbiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12919","article-title":"Mould-reactive T cells for the diagnosis of invasive mould infection-a prospective study","volume":"62","author":"Steinbach","year":"2019","journal-title":"Mycoses;"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu607","article-title":"Multispecific aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections","volume":"211","author":"Stuehler","year":"2015","journal-title":"J Infect Dis"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000227","article-title":"Dynamic, morphotype-specific candida albicans beta-glucan exposure during infection and drug treatment","volume":"4","author":"Wheeler","year":"2008","journal-title":"PloS Pathog"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2010.00720.x","article-title":"Effects of caspofungin, candida albicans and aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs","volume":"60","author":"Salvenmoser","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01268-06","article-title":"Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice","volume":"51","author":"Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh542","article-title":"Liposomal amphotericin b activates antifungal resistance with reduced toxicity by diverting toll-like receptor signalling from TLR-2 to TLR-4","volume":"55","author":"Bellocchio","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000134314.65398.bf","article-title":"Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children","volume":"23","author":"Abzug","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12885-019-6145-8","article-title":"IFN-\u03b3 down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer","volume":"19","author":"Ding","year":"2019","journal-title":"BMC Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27604","article-title":"Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer","volume":"11","author":"Kverneland","year":"2020","journal-title":"Oncotarget;"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01501-x","article-title":"Counteracting CAR T cell dysfunction","volume":"40","author":"Poorebrahim","year":"2021","journal-title":"Oncogene;"},{"key":"B98","doi-asserted-by":"publisher","first-page":"103941","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine;"},{"key":"B99","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.omto.2016.11.005","article-title":"Enhancement of PSMA-directed CAR adoptive immunotherapy by PD-1\/PD-L1 blockade","volume":"4","author":"Serganova","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0458","article-title":"Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells","volume":"19","author":"John","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.critrevonc.2015.10.005","article-title":"Adoptive transfer of aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges","volume":"98","author":"Papadopoulou","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2012.11.014","article-title":"Clinical-scale generation of multi-specific anti-fungal T cells targeting candida, aspergillus and mucormycetes","volume":"15","author":"Tramsen","year":"2013","journal-title":"Cytotherapy;"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.08.031","article-title":"Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy","volume":"157","author":"Dimitriou","year":"2021","journal-title":"Eur J Cancer"},{"key":"B104","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02365-16","article-title":"Pharmacological blockade of the chemokine receptor CCR1 protects mice from systemic candidiasis of hematogenous origin","volume":"61","author":"Lionakis","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2014.02.003","article-title":"Host immune response to infection and cancer: unexpected commonalities","volume":"15","author":"Goldszmid","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00784","article-title":"The tumor microenvironment in the response to immune checkpoint blockade therapies","volume":"11","author":"Petitprez","year":"2020","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3RU1018-378RR","article-title":"M2b macrophage polarization and its roles in diseases","volume":"106","author":"Wang","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10365","article-title":"Aspergillus fumigatus enhances human NK cell activity by regulating M1 macrophage polarization","volume":"20","author":"Zhang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B111","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/JD9.0000000000000044","article-title":"Itraconazole promotes macrophage M1 polarization and phagocytic capacity of macrophage to candida albicans","volume":"2","author":"Zheng","year":"2019","journal-title":"Int J Dermatol Venereology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-02019-6","article-title":"CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene;"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15359","article-title":"Tumor PD-L1 and VEGF expression, and CD8 T cell infiltration predict clinical response to immune checkpoint inhibitors in non-small cell lung cancer","volume":"41","author":"Nojima","year":"2021","journal-title":"Anticancer Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/jof7090698","article-title":"Chronic occupational mold exposure drives expansion of aspergillus-reactive type 1 and type 2 T-helper cell responses","volume":"7","author":"Lauruschkat","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2018.09.002","article-title":"Evaluation of aspergillus and mucorales specific T-cells and peripheral blood mononuclear cell cytokine signatures as biomarkers of environmental mold exposure","volume":"308","author":"Page","year":"2018","journal-title":"Int J Med Microbiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2020.06.006","article-title":"Anti-fungal T cell responses in the lung and modulation by the gut-lung axis","volume":"56","author":"Scheffold","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","article-title":"Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against candida albicans","volume":"176","author":"Bacher","year":"2019","journal-title":"Cell;"},{"key":"B118","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/jof3040051","article-title":"Fungal strategies to evade the host immune recognition","volume":"3","author":"Hern\u00e1ndez-Ch\u00e1vez","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00142","article-title":"Anti-immune strategies of pathogenic fungi","volume":"6","author":"Marcos","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01920","article-title":"Hypoxia: A double-edged sword during fungal pathogenesis","volume":"11","author":"Chung","year":"2020","journal-title":"Front Microbiol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12498","article-title":"Hypoxia attenuates anti-aspergillus fumigatus immune responses initiated by human dendritic cells","volume":"59","author":"Fliesser","year":"2016","journal-title":"Mycoses;"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01318-18","article-title":"Hypoxia promotes immune evasion by triggering \u03b2-glucan masking on the candida albicans cell surface via mitochondrial and cAMP-protein kinase a signaling","volume":"9","author":"Pradhan","year":"2018","journal-title":"mBio;"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231209","article-title":"Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites","volume":"114","author":"Ben-Ami","year":"2009","journal-title":"Blood;"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30852-5","article-title":"Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis","volume":"18","author":"Daver","year":"2017","journal-title":"Lancet Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/ph14040288","article-title":"Is there a place for PD-1-PD-L blockade in acute myeloid leukemia","volume":"14","author":"Jimbu","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0070-8","article-title":"Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes","volume":"32","author":"Daver","year":"2018","journal-title":"Leukemia;"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in Relapsed\/Refractory acute myeloid leukemia: A nonrandomized, open-label, phase II study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov"},{"key":"B129","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/jof7060462","article-title":"Development of a simple and robust whole blood assay with dual Co-stimulation to quantify the release of T-cellular signature cytokines in response to aspergillus fumigatus antigens","volume":"7","author":"Lauruschkat","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003479","article-title":"A virtual infection model quantifies innate effector mechanisms and candida albicans immune escape in human blood","volume":"10","author":"H\u00fcnniger","year":"2014","journal-title":"PloS Comput Biology"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01380","article-title":"Therapeutic targeting of the macrophage immune checkpoint CD47 in myeloid malignancies","volume":"9","author":"Chao","year":"2020","journal-title":"Front Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/jof7121058","article-title":"Invasive fungal infections and targeted therapies in hematological malignancies","volume":"7","author":"Little","year":"2021","journal-title":"J Fungi (Basel)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1018202\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T02:21:33Z","timestamp":1666664493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1018202\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":132,"alternative-id":["10.3389\/fimmu.2022.1018202"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1018202","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"article-number":"1018202"}}